|Mr. O. B. Parrish||Co-Founder and Vice Chairman||175.16k||N/A||84|
|Dr. Mitchell S. Steiner M.D., F.A.C.S||Chief Exec. Officer, Pres and Director||N/A||N/A||56|
|Mr. Daniel Haines||Chief Financial Officer and Chief Operating Officer||N/A||N/A||35|
|Dr. Harry Fisch M.D., F.A.C.S.||Chief Corp. Officer and Director||N/A||N/A||58|
|Mr. Brian James Groch||Chief Commercial Officer||N/A||N/A||50|
The Female Health Company, a medical therapeutics company, develops, manufactures, and markets consumer health care products. The companys pharmaceuticals product portfolio includes Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the Phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial mediterranean fever. It also provides consumer health and medical devices, including PREBOOST benzocaine wipes for premature ejaculation; and FC2, which is female disposable contraceptive device, as well as FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus. The company primarily serves global agencies, non-government organizations, ministries of health, and other governmental agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It has operations in the United States, Brazil, Zimbabwe, South Africa, Angola, the Democratic Republic of the Congo, Tanzania, Malaysia, Spain, France, the United Kingdom, and internationally. The company was founded in 1896 and is headquartered in Miami, Florida.
The Female Health Company’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.